Advaxis Stock Analysis (NASDAQ:ADXS)

Add to My Stocks
$7.94 $0.08 (1.02%) ADXS stock closing price Mar 24, 2017 (Closing)
Watch Robo Advisor Video of ADXS Stock Analysis
Updated on : Mar 24, 2017
previous close
ADXS 7.9 (0%)
S&P 500 2344 (0%)
Closing Price On: Mar 24, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Sector :
5 Quarter Revenue
Revenue Growth
Compared to the industry
Operating Profit
Operating Margin:
Sector Average:
5 Quarter Net Profit
Net Margins
LTM Margin
Debt/Equity Ratio
Debt/Equity Ratio:
Compared to the industry
Cash Flow
Operating cash flow:
Net Income:
Low Debt Burden
Operating Margins
Net Margins
FCF Margin
Rating: ★★★★★★★★★★ (0/5)
Other Metrics
Return on Equity:
Free Cash Flow Margin:
Double Tap To Exit Full Screen

Advaxis Analysis Video

131 5 2

View Advaxis stock analysis video. This is our ADXS analyst opinion covering the buy and sell arguments for ADXS stock.

Advaxis, Inc. Stock Rating (1.2/5)

Our Advaxis stock opinion is based on fundamentals of the company. This Advaxis stock analysis is based on latest Q1 earnings for 2017. The stock price analysis takes into account a company's valuation metrics.

Should you buy ADXS stock?

  • With a debt/equity ratio of  0, Advaxis is comparatively less leveraged than its peers in the Medical sector.

Should you sell ADXS stock?

  • Advaxis registered a negative operating margin of -979.2% (average) over the Trailing Twelve Months (TTM).
  • Advaxis registered an average TTM Net loss of -940.2%.
  • Advaxis has a negative ROE (Return On Equity) of -69.3%, indicating the company is not profitable.
  • The company has negative Free Cash Flows (FCF), with a negative FCF margin of -401.8%.

Comments on this video and Advaxis stock